DDI Study of Evobrutinib and Carbamazepine
NCT05248945
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
14
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Evobrutinib
DRUG:
Carbamazepine
Sponsor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany